Preprint Concept Paper Version 1 This version is not peer-reviewed

COVID-19 Management in Spain. Errors to Avoid and the Need of A Post-Confinement Longitudinal Epidemiological Study

Version 1 : Received: 6 May 2020 / Approved: 8 May 2020 / Online: 8 May 2020 (07:53:54 CEST)

How to cite: Franco, R. COVID-19 Management in Spain. Errors to Avoid and the Need of A Post-Confinement Longitudinal Epidemiological Study. Preprints 2020, 2020050137 (doi: 10.20944/preprints202005.0137.v1). Franco, R. COVID-19 Management in Spain. Errors to Avoid and the Need of A Post-Confinement Longitudinal Epidemiological Study. Preprints 2020, 2020050137 (doi: 10.20944/preprints202005.0137.v1).

Abstract

Some of the European countries affected by COVID-19 have not learned from previous experience in China. Italy did not learn from China and Spain did neither learn from China nor from Italy. Confinement in Spain was postponed due to pressure from economic interests and traveling of infected people, especially from Madrid to the beaches in South-East Spain, was allowed. Strict confinement and border closure came late, when the curve of infected people and the death toll already had the worse trend worldwide. Tests to SARS-CoV-2 RNA detection by PCR, were first unavailable and, later, faulty and/or detecting antibodies and not the virus itself. Instead of mobilizing research laboratories for making tests, and instead of making masks and ventilators, mediatic scientists asked for money for controversial clinical trials and for obtaining a vaccine. In this scenario, common sense indicates that ad hoc measures should be taken at the end of confinement in order to minimize pain. The chain of errors should be avoided in the management of next pandemics by designing Good Practice Rules (GPRs). In addition, post-confinement measures should be implemented as soon as possible to be ready for SARS-CoV-2 return next season. In this sense a longitudinal study in the most affected cities (Madrid, Barcelona, Vitoria and Pamplona) should be performed with the primary objective of detecting carriers with no symptoms, to stratify patients according to symptoms, and to early detection of virus reappearance.

Subject Areas

COVID-19; SARS-CoV-2; pandemic; ethics; public health; longitudinal clinical trial; silent virus carrier

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.